May. 12 at 7:41 PM
$PSEC Investment Summary: Prospect Capital (PSEC)
Analyst Recommendations: Major analysts (including Wells Fargo) have issued drastic "Sell" / "Underweight" ratings, slashing price targets to as low as
$2.00 [MarketBeat].
Financial Health: The fund's assets are shrinking and net asset value (NAV) is declining [Stock Titan]. Consequently, management has officially cut the monthly dividend by 22% to
$0.035.
Vanishing Profits: While the underlying portfolio remains relatively healthy—with non-accruals (bad debts) at a low 0.7% [Seeking Alpha]—bottom-line profits are being eroded by massive management fees and high-cost distributions to preferred shareholders [SEC.gov, Seeking Alpha].
Conflict of Interest: Financial analysts warn of a "dividend trap." Conversely, company executives are aggressively purchasing millions of dollars worth of shares in an attempt to bolster the firm's image and defend the stock price against further declines [MarketBeat].
